Related Experiment Videos
Dyslipidemia in type 2 diabetes mellitus.
Current Diabetes Reports
|June 6, 2007
Summary
Patients with diabetes mellitus (DM) face high cardiovascular risk. Aggressive statin therapy effectively reduces cardiovascular events by lowering low-density lipoprotein cholesterol (LDLC) in these individuals.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Cardiovascular disease (CVD) is a major cause of death in diabetes mellitus (DM).
- DM is considered a risk equivalent for coronary heart disease.
- Diabetic dyslipidemia, characterized by high triglycerides, low HDL, and small dense LDL particles, promotes atherosclerosis.
Purpose of the Study:
- To review the role of lipid profiles in DM-related atherosclerosis.
- To emphasize the benefits of statin therapy in reducing cardiovascular events in diabetic patients.
- To discuss current guidelines for LDLC reduction in DM.
Main Methods:
- Review of primary and secondary prevention studies on statin therapy in DM.
- Analysis of lipid profiles typical in type 2 DM.
- Examination of current treatment guidelines for LDLC targets.
Main Results:
- Aggressive statin therapy significantly reduces cardiovascular end points in patients with DM.
- Current guidelines recommend LDLC < 100 mg/dL for all DM patients.
- Lowering LDLC to < 70 mg/dL may offer additional benefits for very high-risk DM patients.
Conclusions:
- Statin therapy is crucial for managing cardiovascular risk in diabetes mellitus.
- Achieving target LDLC levels is essential for preventing atherosclerosis and cardiovascular events in DM.
- Personalized LDLC goals, especially < 70 mg/dL, may be beneficial for high-risk diabetic individuals.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...